Ambryon Biosciences

CMV early enhancer/chicken β-actin/rabbit β-globin hybrid promoter (CAG)

Synthetic hybrid promoter combining the CMV immediate-early enhancer, the chicken β-actin promoter, and a rabbit β-globin splice acceptor/intron, engineered for very high constitutive expression across mammalian cell types and tissues. One of the strongest promoters available for transgenic animals, viral vectors, and stable cell lines.

Relative StrengthStrong
OriginSynthetic hybrid — CMV enhancer + chicken β-actin promoter/intron
Expression PatternConstitutive

Characteristics

Fuses the CMV immediate-early enhancer, the chicken β-actin promoter and its 5' splice donor, and a rabbit β-globin splice acceptor/intron into a single ~1.7 kb cassette, combining a strong viral enhancer with a housekeeping promoter's transcriptional machinery (Niwa et al. 1991). In a side-by-side lentiviral reporter comparison across eight mammalian cell lines, the CAG-type hybrid (CAGG) is one of the two consistently strongest promoters tested, on par with EF1A and outperforming CMV, UBC, PGK, and SV40 (Qin et al. 2010).

Applications

Standard choice for generating transgenic mice with ubiquitous, high-level reporter or Cre expression, and for driving transgenes in AAV and lentiviral vectors where maximal constitutive output across diverse cell types is needed, including stable cell-line generation. Used as a benchmark "strong promoter" in promoter-comparison studies.

Limitations

At ~1.7 kb, substantially larger than compact alternatives such as EFS or minimal CMV, competing with the size budget of AAV vectors (~4.7 kb capacity) when combined with a sizeable transgene. Retains the CMV enhancer component, and ubiquitous strong promoters of this type carry a documented risk of transgene silencing over time in some in vivo contexts.

Sequence1,733 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Qin et al. (2010). Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter. PLoS ONE — Qin 2010 Promoter Comparison
  2. 2.Niwa et al. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene — Niwa 1991 CAG

Identifiers & revision